J9299 HCPCS Level II code: Injection, nivolumab, 1 mg
J9299 is the HCPCS code for “Injection, nivolumab, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9299Injection, nivolumab, 1 mg
Short description: Injection, nivolumab
HCPCS · United States
Notes for J9299
As CMS prints them, with any note J9299 takes from the headings above it.
Note
- CMS processing note 0127: PUBLICATION 100.2, CHAPTER 15, 50.1.
Medicare details
The indicators CMS publishes with J9299 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2016
Where J9299 sits
- 1J codesDrugs administered other than orally
- 2Active code J9299Injection, nivolumab, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9299 mean?
J9299 is the HCPCS code for “Injection, nivolumab, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9299?
CMS lists J9299’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9299
All J codesJ9293Injection, mitoxantrone hydrochloride, per 5 mgJ9294Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mgJ9295Injection, necitumumab, 1 mgJ9296Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mgJ9297Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mgJ9298Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mgJ9300Injection, gemtuzumab ozogamicin, 5 mgJ9301Injection, obinutuzumab, 10 mgJ9302Injection, ofatumumab, 10 mgJ9303Injection, panitumumab, 10 mgJ9304Injection, pemetrexed (pemfexy), 10 mgJ9305Injection, pemetrexed, not otherwise specified, 10 mg